Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Strategic Asset Allocation Index
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Strategic Asset Allocation Index of 37.1% as of September 2023. Strategic assets (PP&E of CN¥605.79 Million plus long-term investments of CN¥-) total CN¥605.79 Million, measured against net assets of CN¥1.63 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Chongqing Pharscin Pharmaceutical Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Chongqing Pharscin Pharmaceutical Co Ltd Strategic Asset Allocation Index (2016–2021)
This chart shows how Chongqing Pharscin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of September 2023, the index stands at 37.1%, representing strategic assets of CN¥605.79 Million against net assets of CN¥1.63 Billion CNY. See Chongqing Pharscin Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Chongqing Pharscin Pharmaceutical Co Ltd (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Chongqing Pharscin Pharmaceutical Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002907 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 51.7% | CN¥654.21 Million | CN¥654.21 Million | CN¥- | CN¥1.27 Billion | ▼ -5.3 pp |
| 2020 | 57.0% | CN¥673.61 Million | CN¥673.61 Million | CN¥- | CN¥1.18 Billion | ▼ -1.7 pp |
| 2019 | 58.7% | CN¥629.05 Million | CN¥629.05 Million | CN¥- | CN¥1.07 Billion | ▲ +20.2 pp |
| 2018 | 38.5% | CN¥319.51 Million | CN¥319.51 Million | CN¥- | CN¥828.91 Million | ▲ +6.2 pp |
| 2017 | 32.4% | CN¥233.12 Million | CN¥233.12 Million | CN¥- | CN¥719.95 Million | ▼ -3.0 pp |
| 2016 | 35.4% | CN¥163.33 Million | CN¥163.33 Million | CN¥- | CN¥461.42 Million | — |